Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of tetrahydrooxazolopyridoazepine ketone derivative and use thereof

A technology of tetrahydrooxazole and azapinone, applied in the field of tetrahydrooxazolopyridoazepinone derivatives

Active Publication Date: 2022-07-05
XINJIANG TECHN INST OF PHYSICS & CHEM CHINESE ACAD OF SCI
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are few reports on finding anti-cancer active ingredients with low toxicity and high curative effect from natural animals and plants. Therefore, chemically synthesized anti-cancer drugs are still one of the hotspots of domestic and foreign scientists in recent years.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of tetrahydrooxazolopyridoazepine ketone derivative and use thereof
  • A kind of tetrahydrooxazolopyridoazepine ketone derivative and use thereof
  • A kind of tetrahydrooxazolopyridoazepine ketone derivative and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0106] Preparation of Compound A:

[0107] Under the condition of temperature -10℃, dissolve 57.3ml of sodium nitrite, 0.83mol and 100g of ethyl cyanoacetate, 0.83mol of ethyl cyanoacetate in 700ml of pure water, and slowly add 36.6ml of 85% concentrated phosphoric acid, 0.055mol dropwise for a period of time. Continue for 3 hours, heat up to 45 ° C and stir for 1 hour, then add 74 ml of concentrated hydrochloric acid, 0.88 mol, continue to stir overnight at a temperature of 0 ° C, a large amount of white solid is precipitated, and the white compound A is 2-cyano-2- Ethyl hydroxyiminoacetate, does not need to be purified for the next step reaction;

[0108] Preparation of Compound B:

[0109] At room temperature, the obtained white compound A was 43 g of ethyl 2-cyano-2-hydroxyiminoacetate, 0.3 mol of which was dissolved in 500 ml of pure water, and 350 ml of saturated sodium bicarbonate solution was slowly added dropwise with stirring. , then add 156 g of sodium dithionite,...

Embodiment 2

[0162] Preparation of compounds D1-D48:

[0163] 10 mmol of each compound C1-C48 obtained in Example 1 was dissolved in anhydrous dichloromethane, then 10 mL of trifluoroacetic acid was slowly added dropwise, the reaction was carried out at room temperature until all the raw materials disappeared, the reaction solution was concentrated, and a normal silica gel column chromatography gradient was used. Elution, the eluent is the petroleum ether of volume ratio 2:1: ethyl acetate, respectively obtains compound D1-D48, wherein the name of compound D1-D48 is:

[0164] Compound D1 is 2-methyl-5-amino-4-carboxylic acid ethyl ester oxazole, yield: 84%, pale yellow solid;

[0165] 1 H NMR (400MHz, CDCl 3 )δ5.31(s, 2H), 4.33(q, J=7.2Hz, 2H), 2.34(s, 3H), 1.37(t, J=7.1Hz, 3H);

[0166] Compound D2 is 2-ethyl-5-amino-4-carboxylic acid ethyl ester oxazole, yield: 80%, pale yellow solid;

[0167] 1 H NMR (400MHz, CDCl 3 )δ5.58(s, 2H), 4.25(q, J=7.1Hz, 2H), 2.58(q, J=7.6Hz, 2H), 1.28(t...

Embodiment 3

[0260] Preparation of compound E1:

[0261] The compound D1 obtained in Example 2 is 2-methyl-5-amino-4-carboxylic acid ethyl ester 0.17 g, 10 mmol of oxazole was dissolved in 20 mL of anhydrous dioxane, and 0.17 g of cyclohexanamide, 15 mmol was added , then slowly add phosphorus oxychloride 0.38g, 2.5mmol, reflux reaction until all the raw materials disappear, extract with dichloromethane, dry over anhydrous sodium sulfate, concentrate under reduced pressure, use normal silica gel column chromatography gradient elution, wash The removal agent is petroleum ether: ethyl acetate with a volume ratio of 1:1, and the obtained compound E1 is 2-methyl-6,7,8,9-tetrahydrooxazolo[5',4':4,5]pyridine And[1,2-a]azepin-11(5H)-one, yield 75%, pale yellow solid, melting point: 73-75℃;

[0262] 1 H NMR (400MHz, CDCl 3 )δ4.42(t, J=6.1Hz, 2H), 3.08(t, J=6.6Hz, 2H), 2.57(s, 3H), 2.02–1.61(m, 6H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a tetrahydrooxazolopyridoazepine derivative and use thereof, and the specific derivative is tetrahydrooxazolo[5',4':4,5]pyrido[1 ,2- a ]nitrox-11(5 H )-ketone derivatives are E1-E48. In the antitumor activity screening, DOX was used as the positive control; 48 tetrahydrooxazolo[5',4':4,5]pyrido[1,2-derivatives were E1-E48 were investigated. a ]nitrox-11(5 H The inhibitory effect of )-ketone derivatives on Hela human cervical cancer cells, MCF-7 breast cancer cells and A549 lung cancer cells, the results show: compared with the positive control, compounds E5, E8, E9, E20, E26, E28, E32 , E34, E38, E41, E42, E44, E45, E46, E47 and E48 have inhibitory activity on Hela cervical cancer cells; compounds E26, E38, E42, E45, E46 and E47 have inhibitory activity on MCF‑7 breast cancer cells; Compounds E8, E9, E26 and E47 have inhibitory activity against A549 lung cancer cells.

Description

technical field [0001] The invention relates to a tetrahydrooxazolopyridoazepine ketone derivative and use thereof, and specifically designs a tetrahydrooxazolo[5',4':4,5]pyrido[1,2- a] Aza-11(5H)-one derivatives and their uses. The results of cell activity screening showed that 16 compounds had inhibitory activity against Hela cervical cancer cells; 6 compounds had inhibitory activity against MCF-7 breast cancer cells Has inhibitory activity; 4 compounds have inhibitory activity on A549 lung cancer cells. Background technique [0002] According to the statistics of the World Health Organization (WHO), about 10 million people are diagnosed with cancer and about 7 million people die from cancer in the world every year. Become the second killer of human beings after cardiovascular disease. Although most of the chemically synthesized anticancer drugs also have toxic side effects on the normal cells of the human body. However, there are few reports of finding anticancer activ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D498/14A61P35/00
CPCC07D498/14A61P35/00
Inventor 阿吉艾克拜尔·艾萨曾艳聂礼飞胡尔西地·博扎罗夫赵江瑜
Owner XINJIANG TECHN INST OF PHYSICS & CHEM CHINESE ACAD OF SCI